Literature DB >> 28989413

Percutaneous endoscopic gastrostomy (PEG) site infections: a clinical and microbiological study from university teaching hospital, India.

Sushma Krishna1, Sanjeev Singh2, Kavitha R Dinesh1, Remya Kp3, Ismail Siyad4, Shamsul Karim1.   

Abstract

BACKGROUND: Percutaneous endoscopic gastrostomy (PEG) is used to provide enteral access in patients who are unable to swallow. Infection of the stoma is an important complication and there is little data from India on this problem, which can be used to inform infection prevention and prophylactic strategies. AIM: The objective was to assess the prevalence and the role of contributory factors in PEG site infections.
METHODS: A total of 173 patients underwent PEG insertion from January 2011 to May 2012. Clinical and microbiological data were collected for culture-positive cases. Insertion was performed using a standard sterile pull-through technique. Infections were defined as two of: peristomal erythema, induration, and purulent discharge.
RESULTS: A total of 54 PEG infections occurred in 43 patients (28.85%). Seventy-seven organisms were isolated. Pseudomonas aeruginosa was the most common (n=29) followed by coliforms (n=21) and meticillin resistant Staphylococcus aureus (MRSA) (n=6). Thirty-one (72%) received amoxicillin-clavulanic acid as prophylaxis and 12 (28%) were receiving concomitant antibiotics for their underlying conditions. The occurrence of PEG site infections was statistically independent of the administered prophylactic antibiotics (p=0.3).
CONCLUSIONS: This study has demonstrated the importance of PEG sites as a cause of healthcare associated infections. Educating patients on wound care practices would play a significant role in prevention of PEG site infections.

Entities:  

Keywords:  India; PEG site infections; infection prevention

Year:  2014        PMID: 28989413      PMCID: PMC5074112          DOI: 10.1177/1757177414558956

Source DB:  PubMed          Journal:  J Infect Prev        ISSN: 1757-1782


  17 in total

1.  Prospective, randomised, double blind trial of prophylaxis with single dose of co-amoxiclav before percutaneous endoscopic gastrostomy.

Authors:  G Preclik; S Grüne; H G Leser; J Lebherz; W Heldwein; K Machka; A Holstege; W V Kern
Journal:  BMJ       Date:  1999-10-02

2.  The relevance of systemic complications and the different outcomes of subgroups after percutaneous endoscopic gastrostomy (PEG).

Authors:  A J Dormann; H Huchzermeyer; H Lippert
Journal:  Am J Gastroenterol       Date:  2001-06       Impact factor: 10.864

3.  Percutaneous endoscopic gastrostomy sites infected by methicillin-resistant Staphylococcus aureus: impact on outcome.

Authors:  Inder Mainie; Anne Loughrey; Jennifer Watson; Tony C K Tham
Journal:  J Clin Gastroenterol       Date:  2006-04       Impact factor: 3.062

4.  PEG site infections: the emergence of methicillin resistant Staphylococcus aureus as a major pathogen.

Authors:  Kamran A Chaudhary; Owen J Smith; Paul G Cuddy; Wendell K Clarkston
Journal:  Am J Gastroenterol       Date:  2002-07       Impact factor: 10.864

Review 5.  Complications of enteral access.

Authors:  Stephen A McClave; Wei-Kuo Chang
Journal:  Gastrointest Endosc       Date:  2003-11       Impact factor: 9.427

6.  Efficacy of 48-hour post-operative antibiotics prophylaxis for patients undergoing percutaneous endoscopic gastrostomy tube in preventing site infection.

Authors:  Adnan Agha; Dib Alsaudi; Manuele Furnari; Mamdouh M Abdulhadi Ali; Saeed Salim Abdullah Al-Majadah; Vincenzo Savarino; Simona Inferrera; Edoardo G Giannini
Journal:  J Gastrointestin Liver Dis       Date:  2011-06       Impact factor: 2.008

7.  Antibiotic prophylaxis for percutaneous endoscopic gastrostomy. A prospective, randomized, double-blind clinical trial.

Authors:  N K Jain; D E Larson; K W Schroeder; D D Burton; K P Cannon; R L Thompson; E P DiMagno
Journal:  Ann Intern Med       Date:  1987-12       Impact factor: 25.391

8.  Peristomal infection after percutaneous endoscopic gastrostomy: a 7-year surveillance of 297 patients.

Authors:  Helena Duarte; Carla Santos; Manuel Luís Capelas; Jorge Fonseca
Journal:  Arq Gastroenterol       Date:  2012-12

9.  Prevention of percutaneous endoscopic gastrostomy site infections caused by methicillin-resistant Staphylococcus aureus.

Authors:  G Gopal Rao; M Osman; L Johnson; D Ramsey; S Jones; H Fidler
Journal:  J Hosp Infect       Date:  2004-09       Impact factor: 3.926

10.  Gastrostomy without laparotomy: a percutaneous endoscopic technique.

Authors:  M W Gauderer; J L Ponsky; R J Izant
Journal:  J Pediatr Surg       Date:  1980-12       Impact factor: 2.545

View more
  3 in total

1.  Percutaneous endoscopic gastrostomy site infections-Incidence and risk factors.

Authors:  Kayal Vizhi; Harshavardhan B Rao; Rama P Venu
Journal:  Indian J Gastroenterol       Date:  2018-02-23

2.  Clinical characteristics and pathogens in percutaneous endoscopic gastrostomy site infection in patients with head and neck cancer: A 16-year retrospective study.

Authors:  Jihyu Oh; So Yeon Park; Jin Seo Lee; Ji-Young Park; Seo Hu Lee
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-09-29

3.  First Documented Case of Percutaneous Endoscopic Gastrostomy (PEG) Tube-Associated Bacterial Peritonitis due to Achromobacter Species with Literature Review.

Authors:  Nishant Tripathi; Niki Koirala; Hirotaka Kato; Tushi Singh; Kishore Karri; Kshitij Thakur
Journal:  Case Rep Gastrointest Med       Date:  2020-01-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.